The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Thursday, August 13, 2026

Subject of the day

SYK

Concerning the House

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

United States · www.stryker.com

The Long Run

FY 2009–2025 · 17 years

LineLatestCAGRTrend
Revenue$25.12B+8.6%
Gross profit$3.33B-1.3%
Operating income$4.89B+7.3%
Net income$654.00M-2.7%
Cash from ops$5.04B+9.5%
Quotation

$341.09

-6.12 (-1.8%)

52w hi$390.37
52w lo$281.83
Vol1.64M
As ofAug 13
The Verdict

Hold

Our score +0.17

Short-0.09
Medium+0.28
Long+0.44

computed 2026-08-13

By the Numbers

Stryker Corporation

Healthcare · Medical Devices

Market cap$130.83B
Enterprise value$145.15B
Trailing P/E35.35x
Forward P/E20.35x
EV / EBITDA19.68x
P / S (ttm)5.06x
Profit margin14.4%
Return on equity16.5%
Revenue growth+9.4%
Earnings growth+44.1%
Debt / equity64.39
Risk Metrics
Beta vs SPX0.55
Corr SPX0.36
Annual vol24.5%
Annual ret+5.3%
Sharpe0.21
Max DD-30.0%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental+0.30
Sector+0.12
Technical+0.02
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$345.02$346.60$339.53$341.091.64M
Aug 12$342.19$347.46$339.35$347.212.09M
Aug 11$344.45$349.77$344.45$348.151.63M
Aug 10$337.03$345.93$335.00$345.811.66M
Aug 7$336.67$340.00$332.54$339.031.85M